2018 Annual Meeting | C95 - Actualización Sobre las Infecciones del Sistema Nervioso Central y la Medicina Tropical
03:30 PM - 03:40 PM | Luncheon |
Introduction
Oscar H. Del Brutto, MD, FAAN |
03:40 PM - 04:05 PM | Speaker |
Neuroviruses Emerging in the Americas Study (NEAS)
Carlos A. Pardo-Villamizar, MD |
04:05 PM - 04:30 PM | Speaker |
Advances in the Diagnosis and Treatment of Neurocisticercosis
Oscar H. Del Brutto, MD, FAAN |
04:30 PM - 04:55 PM | Speaker |
Nutritional Diseases of the Nervous System in the Tropics
Gustavo C. Roman, MD, FAAN |
04:55 PM - 05:30 PM | Speaker |
Case Discussions
Oscar H. Del Brutto, MD, FAAN, Daniel Ontaneda, MD, PhD, FAAN, Carlos A. Pardo-Villamizar, MD, Gustavo C. Roman, MD, FAAN |
Oscar H. Del Brutto, MD, FAAN | Dr. Del Brutto has received research support from Universidad Espiritu Santo - Ecuador. |
Joseph R. Zunt, MD | The institution of Dr. Zunt has received research support from NIH. |
Gustavo C. Roman, MD, FAAN | The institution of Dr. Roman has received research support from Brain Chamistry Labs. |
Daniel Ontaneda, MD, PhD, FAAN | Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech. |
Carlos A. Pardo-Villamizar, MD | The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |